SCIENTIFIC
PUBLICATIONS

Stay up-to-date with the latest scientific advancements from PRISM. Discover our complete library of peer-reviewed publications, showcasing cutting-edge research

Epigenetic Studies Revealed a Ghost Proteome in PC1/3 KD Macrophages under Antitumoral Resistance Induced by IL-10
  • Recherche

Epigenetic Studies Revealed a Ghost Proteome in PC1/3 KD Macrophages under Antitumoral Resistance Induced by IL-10
Spinal Cord Injury: Animal Models, Imaging Tools and the Treatment Strategies
  • Recherche

Spinal Cord Injury: Animal Models, Imaging Tools and the Treatment Strategies
Identification of prognostic markers in diffuse midline gliomas H3K27M-mutant
  • Recherche

Identification of prognostic markers in diffuse midline gliomas H3K27M-mutant
Distinct Protein Expression Networks are Activated in Microglia Cells after Stimulation with IFN-γ and IL-4
  • Recherche

Distinct Protein Expression Networks are Activated in Microglia Cells after Stimulation with IFN-γ and IL-4
Complementary and alternative medicine use in glioma patients in France
  • Clinic

Complementary and alternative medicine use in glioma patients in France
[GEFPICS’ guidelines for management of breast cancer tissue samples in the neoadjuvant setting]
  • Clinic

[GEFPICS’ guidelines for management of breast cancer tissue samples in the neoadjuvant setting]
PC1/3 KD Macrophages Exhibit Resistance to the Inhibitory Effect of IL-10 and a Higher TLR4 Activation Rate, Leading to an Anti-Tumoral Phenotype
  • Recherche

PC1/3 KD Macrophages Exhibit Resistance to the Inhibitory Effect of IL-10 and a Higher TLR4 Activation Rate, Leading to an Anti-Tumoral Phenotype
Imaging necrosis during treatment is associated with worse survival in EORTC 26101 study
  • Clinic

Imaging necrosis during treatment is associated with worse survival in EORTC 26101 study
Long-term evaluation of sound localisation in single-sided deaf adults fitted with a BAHA device
  • Clinic

Long-term evaluation of sound localisation in single-sided deaf adults fitted with a BAHA device
Hormonal therapies in uterine sarcomas, aggressive angiomyxoma, and desmoid-type fibromatosis
  • Clinic

Hormonal therapies in uterine sarcomas, aggressive angiomyxoma, and desmoid-type fibromatosis
Molecular targeted therapy of glioblastoma
  • Clinic

Molecular targeted therapy of glioblastoma
Underweight and weight loss are predictors of poor outcome in patients with brain metastasis
  • Clinic

Underweight and weight loss are predictors of poor outcome in patients with brain metastasis